MVP 1.92% 53.0¢ medical developments international limited

Ann: Penthrox approved for sale in Taiwan, page-5

  1. 1,953 Posts.
    lightbulb Created with Sketch. 187
    Don't you think the SP had a number of these announcements built into it? I'm not complaining, my buy order is yet to be filled...it will bounce in 2017 on the back of increased revenue realised from the deals announced recently, including the space chamber in the US. This is a share I'm happy to hold and accumulate, MVP is the company of the future despite its propensity to attract the downward playing bots.
 
watchlist Created with Sketch. Add MVP (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.